The Justice Department on June 23, 2026, announced charges against 455 defendants, including 90 licensed medical professionals, in connection with more than $6.5 billion in alleged false claims submitted to Medicare, Medicaid, and other federal health programs [1]. The action, designated the 2026 National Health Care Fraud Takedown, is the largest by defendant count in DOJ history [1][2]. Cases span 56 federal districts across 45 states and territories [1].
The charged schemes fall into several categories: wound care allograft billing fraud, telehealth billing abuse, hospice fraud, and opioid diversion [1][2]. Prosecutors allege that defendants submitted or directed the submission of claims for services not rendered, not medically necessary, or predicated on unlawful prescriptions [2]. The Health Care Fraud Statute, 18 U.S.C. § 1347, and the Anti-Kickback Statute form the primary federal charging vehicles, with additional counts under controlled-substance laws where opioid diversion is alleged [2]. All 50 state Medicaid Fraud Control Units participated in the investigation, a level of coordination that signals institutional commitment well beyond prior takedowns [1][3].
The enforcement action involved the HHS Office of Inspector General, the FBI, and the Centers for Medicare and Medicaid Services, alongside DOJ's Consumer Protection Branch and U.S. Attorney's Offices nationwide [1][3]. Attorney General Todd Blanche and FBI Director Kash Patel were among the senior officials associated with the announcement, with CMS Administrator Mehmet Oz and HHS Secretary Robert F. Kennedy Jr. also cited in connection with the interagency effort [1]. The coordinated federal-state structure reflects a deliberate prosecutorial strategy: by activating every state Medicaid Fraud Control Unit simultaneously, investigators contained the risk that targets in one district would be tipped off by arrests in another [2].
The immediate procedural posture varies by district. Some defendants face initial appearances while others are already in detention proceedings or plea negotiations [2]. The scale of the action, 455 defendants across more than four dozen districts, means case resolution will extend over multiple years. Defense counsel in telehealth and wound-care cases are expected to contest medical-necessity determinations and the adequacy of prescriber oversight as threshold issues [2]. Given the record defendant count and the explicit focus on Medicaid and vulnerable populations, this takedown will serve as a benchmark for data-driven federal health care fraud prosecution in the near term [1][3].